AAAAAA
Results:
1-8
|
Results: 8
Authors:
Smith, MP
Ludlam, CA
Collins, PW
Hay, CRM
Wilde, JT
Grigeri, A
Melsen, T
Savidge, GF
Citation: Mp. Smith et al., Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding, THROMB HAEM, 86(4), 2001, pp. 949-953
Authors:
Negrier, C
Hay, CRM
Citation: C. Negrier et Crm. Hay, The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa, SEM THROMB, 26(4), 2000, pp. 407-412
Authors:
Hay, CRM
Baglin, TP
Collins, PW
Hill, FGH
Keeling, DM
Citation: Crm. Hay et al., The diagnosis and management of factor VIII and IX inhibitors: A guidelinefrom the UK Haemophilia Centre Doctors' Organization (UKHCDO), BR J HAEM, 111(1), 2000, pp. 78-90
Authors:
Busuttil, DP
Hay, CRM
Lewis, MA
Wynn, RF
Citation: Dp. Busuttil et al., Aggressive multiple modality therapy for varicella-associated purpura fulminans, BR J HAEM, 110(4), 2000, pp. 1012-1013
Authors:
Cumming, AM
Olujohungbe, A
Keeney, S
Singh, H
Hay, CRM
Serjeant, GR
Citation: Am. Cumming et al., The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke, BR J HAEM, 107(3), 1999, pp. 569-571
Authors:
Hay, CRM
Citation: Crm. Hay, Why do inhibitors arise in patients with haemophilia A?, BR J HAEM, 105(3), 1999, pp. 584-590
Authors:
Hay, CRM
Citation: Crm. Hay, Acquired haemophilia, BAIL CLIN H, 11(2), 1998, pp. 287-303
Authors:
Rustom, R
Leggat, H
Tomura, HR
Hay, CRM
Bone, JM
Citation: R. Rustom et al., Plasma thrombomodulin in renal disease: effects of renal function and proteinuria, CLIN NEPHR, 50(6), 1998, pp. 337-341
Risultati:
1-8
|